BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21104660)

  • 21. [A case of surgical resection for metachronous multiple liver metastases of chromophobe cell renal carcinoma].
    Kikuchi E; Tanomogi H; Hasegawa S; Shimizu K; Yamataka K; Miyakita M
    Hinyokika Kiyo; 1998 Oct; 44(10):715-7. PubMed ID: 9850836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous nephrectomy and right hepatectomy for metastatic chromophobe renal cell carcinoma: report of a case and review of the literature.
    Talarico F; Buli P; Iusco D; Sangiorgi A; Jovine E
    Chir Ital; 2007; 59(2):257-61. PubMed ID: 17500184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluation.
    Huang Z; Du Y; Zhang X; Liu H; Liu S; Xu T
    Eur J Surg Oncol; 2019 Jul; 45(7):1246-1252. PubMed ID: 30760414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Unusual metastasis of renal carcinoma].
    Vidart A; Fehri K; Pfister C
    Ann Urol (Paris); 2006 Aug; 40(4):211-9. PubMed ID: 16970064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consideration of the prognostic factors influencing survival after lung metastasectomy of renal cell carcinoma].
    Nonami Y; Kume M; Sasaguri S; Shuuin T; Moriki T
    Kyobu Geka; 2003 Jan; 56(1):41-6. PubMed ID: 12607252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of renal cancer and its metastases.
    Ulrich W; Buxbaum P; Holzner JH
    Semin Surg Oncol; 1988; 4(2):143-8. PubMed ID: 3393778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
    Zhang M; Wah C; Epstein JI
    Am J Surg Pathol; 2014 Nov; 38(11):1516-21. PubMed ID: 25140895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment of metastases from renal cell carcinoma.
    Antonelli A; Zani D; Cozzoli A; Cunico SC
    Arch Ital Urol Androl; 2005 Jun; 77(2):125-8. PubMed ID: 16146280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
    Procopio G; Verzoni E; Gevorgyan A; Mancin M; Pusceddu S; Catena L; Platania M; Guadalupi V; Martinetti A; Bajetta E
    Oncology; 2007; 73(3-4):204-9. PubMed ID: 18418013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Operative therapy in disease progression and local recurrence of renal cell carcinoma.
    Fischer CG; Schmid H
    Urol Int; 1999; 63(1):10-5. PubMed ID: 10592484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control.
    Gardner CS; Ensor JE; Ahrar K; Huang SY; Sabir SH; Tannir NM; Lewis VO; Tam AL
    J Bone Joint Surg Am; 2017 Nov; 99(22):1916-1926. PubMed ID: 29135665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and survival of osseous renal cell carcinoma metastases.
    Evenski A; Ramasunder S; Fox W; Mounasamy V; Temple HT
    J Surg Oncol; 2012 Dec; 106(7):850-5. PubMed ID: 22623216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone metastases from renal cell carcinoma: patient survival after surgical treatment.
    Fottner A; Szalantzy M; Wirthmann L; Stähler M; Baur-Melnyk A; Jansson V; Dürr HR
    BMC Musculoskelet Disord; 2010 Jul; 11():145. PubMed ID: 20598157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma.
    Winter H; Meimarakis G; Angele MK; Hummel M; Staehler M; Hoffmann RT; Hatz RA; Löhe F
    J Urol; 2010 Nov; 184(5):1888-94. PubMed ID: 20846691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney metastases.
    Dresler CM
    Chest Surg Clin N Am; 1998 Feb; 8(1):127-9. PubMed ID: 9515177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of bone metastases from renal cell carcinoma].
    Hoshi S; Orikasa S; Yoshikawa K; Metoki R; Tochigi T; Ono K; Saitoh S; Satoh M; Ohyama C; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):649-54. PubMed ID: 2051704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
    Kuczyk M; Wegener G; Jonas U
    Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal cell carcinoma metastatic to the skin.
    Koga S; Tsuda S; Nishikido M; Matsuya F; Saito Y; Kanetake H
    Anticancer Res; 2000; 20(3B):1939-40. PubMed ID: 10928130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.